Developing AI based mobile applications that identify genetic disorders
in pediatric patients

0 million
Children a year are born with chromosomal abnormalities; many never receiving adequate treatment or diagnosis
0,000
Newborn babies die globally due to congenital disorders within four weeks of their birth

Through early detection, newborn deaths and hospitalizations can be significantly reduced.

Developing AI based mobile applications that identify genetic disorders 
in pediatric patients

0 million
Children a year are born with chromosomal abnormalities; many never receiving adequate treatment or diagnosis
0,000
Newborn babies die globally due to congenital disorders within four weeks of their birth

Through early detection, newborn deaths and hospitalizations can be significantly reduced.

Developing AI based mobile applications that identify the phenotypes of genetic disorders 
in pediatric patients

0 million
Children a year are born with chromosomal abnormalities; many never receiving adequate treatment or diagnosis
0,000
Newborn babies die globally due to congenital disorders within four weeks of their birth

Through early detection, newborn deaths and hospitalizations can be significantly reduced.

MGeneRx is developing an artificial intelligence platform developed by rare disease experts, physicians and engineers that can instantly identify a child’s risk for congenital birth defects using biometric analysis.

Our Approach

With over 8,000 identified genetic disorders, current common newborn DNA tests only detect approximately 20 of them. We are working to address this by developing cost effective screening that identifies the phenotypes of genetic anomalies.

Our application was evaluated on thousands of pediatric patients from 28 countries with 128 different genetic conditions

With over 8,000 identified genetic disorders, current common newborn DNA tests only detect approximately 20 of them. We are working to address this by developing cost effective screening that identifies the phenotypes of genetic anomalies.

Our application was evaluated on thousands of pediatric patients from 28 countries with 128 different genetic conditions

With over 8,000 identified genetic disorders, current common newborn DNA tests only detect approximately 20 of them. We are working to address this by developing cost effective screening that identifies the phenotypes of genetic anomalies.

Our application was evaluated on thousands of pediatric patients from 28 countries with 128 different genetic conditions

Our Solution

The artificial intelligence behind our simple mobile interface has learned the phenotypes of thousands of real patients to detect genetic disorders in newborns and children

Our Solution

The artificial intelligence behind our simple mobile interface has learned the phenotypes of thousands of real patients to detect genetic disorders in newborns and children

Learn More
Learn More

Our Partners

MGeneRx works in close collaboration with the following organizations

In the Press

Learn more about our programs and our work in improving newborn health outcomes with digital health screening platforms

Ready to Learn More?

WOULD YOU LIKE TO BE A PART OF OUR ENDEAVOR TO ADDRESS DIGITAL GENETIC DISORDERS?

Contact Us